Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment

被引:14
|
作者
Mussa, Alessandro [1 ]
Bertorello, Nicoletta [2 ]
Porta, Francesco [1 ]
Galletto, Chiara [2 ]
Nicolosi, Mario Guido [3 ]
Manicone, Rosaria [2 ]
Corrias, Andrea [1 ]
Fagioli, Franca [2 ]
机构
[1] Univ Turin, Regina Margherita Children Hosp, Dept Pediat Endocrinol & Diabetol, Div Pediat Endocrinol, I-10126 Turin, Italy
[2] Univ Turin, Dept Pediat Oncohematol, I-10126 Turin, Italy
[3] St Anna Hosp, Dept Gynecol & Obstet, Turin, Italy
关键词
Pediatrics; Childhood leukemia; Bone complications; Quantitative ultrasound; Fractures; PHALANGEAL QUANTITATIVE ULTRASOUND; YOUNG-ADULT SURVIVORS; HUMAN FINGER PHALANGES; MINERAL DENSITY; FRACTURE RISK; CHILDREN; TURNOVER; PROPAGATION; GEOMETRY; GROWTH;
D O I
10.1016/j.bone.2009.12.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Bone impairment is a well-known complication in childhood acute lymphoblastic leukemia (ALL) survivors but less is known about bone dynamics during ALL therapy. We longitudinally assessed by Quantitative Ultrasound (QUS) skeletal modifications during this treatment. Materials and methods: Forty-four newly diagnosed ALL children underwent bone measurement by QUS parameters BTT (Bone Transmission Time) and AD-SoS (Amplitude-Dependent Speed of Sound), mainly reliant on bone density and cortical thickness, respectively. Measurements were performed at diagnosis, and 6, 12, and 24 months thereafter. The occurrence of skeletal complications such as fractures, vertebral collapse, osteonecrosis, and osteopenia was related to measurement outcome. Results: A rapid deterioration of bone properties measured by Bit and AD-SoS was evident in the first semester of therapy (p<0.001). Subsequently, the next measurements were characterized by progressive uncoupling of the two QUS parameters (p<0.001). These were both significantly reduced at the end of therapy (p<0.001). Twelve subjects with in-treatment skeletal complications displayed an almost two-fold decrease of both parameters (p<0.001). Bit decreasing more than 1 Standard Deviation (SD) over 6 months of therapy was able to predict skeletal complication occurrence (p<0.001). Conclusion: This report represents the largest longitudinal cohort systematically submitted to bone condition assessment from the beginning to the end of therapy for childhood ALL. Bone deterioration occurs early and persists throughout therapy, consistent with bone properties uncoupling. This pattern possibly reflects an initial impairment of both mineral density and cortical thickness with a subsequent recovery of this latter. QUS permits an early detection of bone deterioration and related skeletal complications in childhood ALL. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1016 / 1020
页数:5
相关论文
共 50 条
  • [21] Patterns and Outcomes of Acute Central Nervous System Complications During Treatment of Childhood Acute Lymphoblastic Leukemia: A Single-center Experience
    Hamoda, Asmaa
    Bedair, Mohamed
    Semary, Samah Fathy
    Youssef, Ayda
    Hafez, Hanafy
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (02) : 72 - 79
  • [22] Obesity in patients with acute lymphoblastic leukemia in childhood
    Iughetti, Lorenzo
    Bruzzi, Patrizia
    Predieri, Barbara
    Paolucci, Paolo
    ITALIAN JOURNAL OF PEDIATRICS, 2012, 38
  • [23] Herpes Simplex Virus Reactivation and Disease during Treatment for Childhood Acute Lymphoblastic Leukemia
    Lauten, M.
    Guettel, C.
    Haertel, C.
    Erdlenbruch, B.
    KLINISCHE PADIATRIE, 2014, 226 (03): : 188 - 189
  • [24] The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia
    Vitanza, Nicholas A.
    Hogan, Laura E.
    Zhang, Guangxiang
    Parker, Robert I.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (05) : 356 - 361
  • [25] Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia
    Elitzur, Sarah
    Houri-Shtrecher, Revital
    Yackobovitz-Gavan, Michal
    Avrahami, Galia
    Barzilai, Shlomit
    Gilad, Gil
    Lebenthal, Yael
    Phillip, Moshe
    Stark, Batia
    Yaniv, Isaac
    Shalitin, Shlomit
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2017, 30 (08) : 869 - 877
  • [26] Biological Features of Bone Marrow Mesenchymal Stromal Cells in Childhood Acute Lymphoblastic Leukemia
    Genitsari, Stella
    Stiakaki, Eftichia
    Perdikogianni, Chryssoula
    Martimianaki, Georgia
    Pelagiadis, Iordanis
    Pesmatzoglou, Margarita
    Kalmanti, Maria
    Dimitriou, Helen
    TURKISH JOURNAL OF HEMATOLOGY, 2018, 35 (01) : 19 - 26
  • [27] Acute Endocrine and Metabolic Complications During Treatment in Childhood Acute Lymphoblastic Leukemia Patients: Retrospective Study
    Evim, Melike Sezgin
    Tobcu, Zeynep
    Guler, Salih
    Ongen, Yasemin Denkboy
    Gunes, Adalet Meral
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2023, 21 (01): : 1 - 8
  • [28] Pharmacogenomic Variations in Treatment Protocols for Childhood Acute Lymphoblastic Leukemia
    Yang, Yung-Li
    Lin, Dong-Tsamn
    Chang, Sheng-Kai
    Lin, Shu-Rung
    Lin, Shu-Wha
    Chiou, Rong-Jing
    Yen, Ching-Tzu
    Lin, Kai-Hsin
    Jou, Shiann-Tarng
    Lu, Meng-Yao
    Chang, Hsiu-Hao
    Chang, Wan-Hui
    Lin, Kuo-Sin
    Hu, Chung-Yi
    PEDIATRIC BLOOD & CANCER, 2010, 54 (02) : 206 - 211
  • [29] Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
    Malczewska, Marta
    Kosmider, Kamil
    Bednarz, Kinga
    Ostapinska, Katarzyna
    Lejman, Monika
    Zawitkowska, Joanna
    CANCERS, 2022, 14 (08)
  • [30] A Randomized Trial Investigating an Exercise Program to Prevent Reduction of Bone Mineral Density and Impairment of Motor Performance During Treatment for Childhood Acute Lymphoblastic Leukemia
    Hartman, A.
    Winkel, M. L. te
    van Beek, R. D.
    Keizer-Schrama, S. M. P. F. de Muinck
    Kemper, H. C. G.
    Hop, W. C. J.
    van den Heuvel-Eibrink, M. M.
    Pieters, R.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (01) : 64 - 71